NINGBO INNO PHARMCHEM CO.,LTD. is pleased to highlight the significant and growing importance of {4-[(5,6-Diphenyl-2-pyrazinyl)(isopropyl)amino]butoxy}acetic Acid within the pharmaceutical research and development sector. This compound, identified by CAS Number 475085-57-5, is recognized for its potent biological activity and its critical role as both an active metabolite and a key intermediate in the synthesis of vital therapeutic agents.

The primary driver behind the increasing demand for this compound is its function as a selective and potent agonist for the human IP receptor. This interaction is fundamental in the therapeutic approach to pulmonary arterial hypertension (PAH), a severe and progressive condition affecting the arteries in the lungs and the right side of the heart. By activating the IP receptor, the compound promotes vasodilation and inhibits platelet aggregation, thereby alleviating the symptoms and progression of PAH. Understanding the specific IP receptor agonist properties is crucial for drug developers aiming to create more effective treatments.

Furthermore, {4-[(5,6-Diphenyl-2-pyrazinyl)(isopropyl)amino]butoxy}acetic Acid is known as the active metabolite of Selexipag, an important drug used in the management of PAH. This relationship makes it an indispensable reference standard for pharmacokinetic studies, drug metabolism analysis, and impurity profiling. Pharmaceutical companies rely on accurate sources of this compound to ensure the quality, safety, and efficacy of their Selexipag-based products. The need to buy {4-[(5,6-Diphenyl-2-pyrazinyl)(isopropyl)amino]butoxy}acetic acid from trusted suppliers like NINGBO INNO PHARMCHEM CO.,LTD. is paramount for maintaining research integrity.

The market for pharmaceutical intermediates is highly competitive, with a strong emphasis on purity, consistent supply, and competitive pricing. Researchers and manufacturers are constantly seeking reliable suppliers who can provide high-quality CAS 475085-57-5 at a favorable pharmaceutical intermediate price. NINGBO INNO PHARMCHEM CO.,LTD. is committed to meeting these demands by offering this critical compound with guaranteed purity and exceptional service. Our focus on quality and customer satisfaction ensures that our partners can advance their research without interruption.

The compound's chemical synthesis pathways are complex, requiring specialized expertise. As a leading supplier, NINGBO INNO PHARMCHEM CO.,LTD. invests in advanced manufacturing processes to ensure efficient and high-yield production. Whether for in-depth drug metabolism studies or for use as a selexipag impurity, the availability of this compound is essential for scientific progress. We are dedicated to supporting the global research community by providing access to essential chemicals that drive innovation in medicine.